UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of October, 2024.

Commission File Number: 001-39530



ImmunoPrecise Antibodies Ltd.
(Exact Name of Registrant as Specified in Charter)

3204 - 4464 Markham Street, Victoria, British Columbia V8Z 7X8
(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F  ⊠  Form 40-F □

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

  IMMUNOPRECISE ANTIBODIES LTD.
     
Date:   October 11, 2024 By: /s/ Kristin Taylor
  Name: Kristin Taylor
  Title: Chief Financial Officer

EXHIBIT INDEX

99.1 Amended Notice of Annual General and Special Meeting dated October 10, 2024


   
Date: October 10, 2024   510 Burrard St, 3rd Floor
Vancouver BC, V6C 3B9
www.computershare.com

To: All Canadian Securities Regulatory Authorities

AMENDED - SEE HIGHLIGHTED

Subject: IMMUNOPRECISE ANTIBODIES LTD.

Dear Sir/Madam:

 

We advise of the following with respect to the upcoming Meeting of Security Holders for the subject Issuer:

Meeting Type : Annual General Meeting
Record Date for Notice of Meeting : October 15, 2024
Record Date for Voting (if applicable) : October 15, 2024
Beneficial Ownership Determination Date : October 15, 2024
Meeting Date : November 14, 2024
Meeting Location (if available) : Virtual Meeting
Issuer sending proxy related materials directly to NOBO: No
Issuer paying for delivery to OBO: No
   
Notice and Access (NAA) Requirements:  
     NAA for Beneficial Holders No
     NAA for Registered Holders No

Voting Security Details:    
     

Description

CUSIP Number

ISIN

COMMON

45257F200

CA45257F2008

 

Sincerely,

Computershare

Agent for IMMUNOPRECISE ANTIBODIES LTD.

Grafico Azioni ImmunoPrecise Antibodies (NASDAQ:IPA)
Storico
Da Dic 2024 a Gen 2025 Clicca qui per i Grafici di ImmunoPrecise Antibodies
Grafico Azioni ImmunoPrecise Antibodies (NASDAQ:IPA)
Storico
Da Gen 2024 a Gen 2025 Clicca qui per i Grafici di ImmunoPrecise Antibodies